193 related articles for article (PubMed ID: 15762683)
1. Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells.
Lin YH; Chung CK; Chen CT; Liang HF; Chen SC; Sung HW
Biomacromolecules; 2005; 6(2):1104-12. PubMed ID: 15762683
[TBL] [Abstract][Full Text] [Related]
2. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
[TBL] [Abstract][Full Text] [Related]
4. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
5. Effects of incorporation of poly(gamma-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency.
Peng SF; Yang MJ; Su CJ; Chen HL; Lee PW; Wei MC; Sung HW
Biomaterials; 2009 Mar; 30(9):1797-808. PubMed ID: 19110309
[TBL] [Abstract][Full Text] [Related]
6. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Chacun H; Ponchel G
Eur J Pharm Biopharm; 2008 Jun; 69(2):436-44. PubMed ID: 18395430
[TBL] [Abstract][Full Text] [Related]
7. In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid).
Akagi T; Higashi M; Kaneko T; Kida T; Akashi M
Macromol Biosci; 2005 Jul; 5(7):598-602. PubMed ID: 15991216
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
[TBL] [Abstract][Full Text] [Related]
9. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
10. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier.
Akagi T; Kaneko T; Kida T; Akashi M
J Control Release; 2005 Nov; 108(2-3):226-36. PubMed ID: 16125267
[TBL] [Abstract][Full Text] [Related]
12. Microstructure formation and property of chitosan-poly(acrylic acid) nanoparticles prepared by macromolecular complex.
Chen Q; Hu Y; Chen Y; Jiang X; Yang Y
Macromol Biosci; 2005 Oct; 5(10):993-1000. PubMed ID: 16211548
[TBL] [Abstract][Full Text] [Related]
13. Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(gamma-glutamic acid)-graft-L-phenylalanine copolymers.
Akagi T; Higashi M; Kaneko T; Kida T; Akashi M
Biomacromolecules; 2006 Jan; 7(1):297-303. PubMed ID: 16398528
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
15. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.
Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW
Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557
[TBL] [Abstract][Full Text] [Related]
16. Transmucosal macromolecular drug delivery.
Prego C; García M; Torres D; Alonso MJ
J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
[TBL] [Abstract][Full Text] [Related]
19. Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations.
Sonaje K; Chuang EY; Lin KJ; Yen TC; Su FY; Tseng MT; Sung HW
Mol Pharm; 2012 May; 9(5):1271-9. PubMed ID: 22462641
[TBL] [Abstract][Full Text] [Related]
20. Adsorption of hematite nanoparticles onto Caco-2 cells and the cellular impairments: effect of particle size.
Zhang W; Kalive M; Capco DG; Chen Y
Nanotechnology; 2010 Sep; 21(35):355103. PubMed ID: 20693617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
